Click on the circle icons to view more information about each section.
Speed of action
Data from two Phase 3 studies demonstrated that Eroxon® helps men get an erection within 10 minutes. In contrast, 'on demand' oral treatments typically take 30 -60 minutes to act.
Enables spontaneity
Because Eroxon® is a fast-acting topical treatment 1, it has the potential to remove the need for planning of sex associated with oral PDE5i medications.
Supports intimacy and partner involvement
As evidenced in the clinical trials Eroxon® topical application and speed of onset means it can form part of foreplay and support intimate sexual experience. The topical application also encourages partner involvement.
Efficacy and safety profile
Eroxon® was shown to be an effective treatment for ED throughout the study phase of the development process and demonstrated a significantly higher statistical improvement across all ED patient severities than before treatment, along with an excellent safety profile.